Stock Screener App

Frei -

Installieren

0.5842

5.41% -0.0334

Aprea Therapeutics Inc (APRE)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Aprea Therapeutics Inc-Aktie (APRE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Operating Expenses	17.54% 4.0322	3.4304	2.6464	3.1192	3.5059
Operating Income/Loss	17.54% -4.0322	-3.4304	-2.6431	-3.1174	-3.3878
Income Tax Expense/Benefit	-	-	-	-	-
Net Income/Loss	9.23% -3.5913	-3.2879	-2.4556	-2.9724	-3.2389
Basic Average Shares	264.19% 53.48	14.69	-	6.3729	6.0833
Diluted Average Shares	264.19% 53.48	14.69	-	6.3729	6.0833
Basic Earnings Per Share	68.18% -0.07	-0.22	-	-0.47	-0.53
Diluted Earnings Per Share	68.18% -0.07	-0.22	-	-0.47	-0.53

OLMA

$6.58

4.22%

ZVRA

$9.94

3.21%

SLDB

$5.53

3.66%

AVTX

$11.27

6.16%

NVCT

$18.60

1.74%

WVE

$3.13

1.88%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters